VFMCRP announces U.S. Court upholds validity of Velphoro® patent
A further ANDA patent infringement lawsuit against Teva based on patents no. 10,682,376, no. 10,695,367 and no 11,013,761, all expiring in May 2029 remains pending. 「CSL Vifor welcomes the d......